日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fragment-Based Development of Small Molecule Inhibitors Targeting Mycobacterium tuberculosis Cholesterol Metabolism.

基于片段的小分子抑制剂开发靶向结核分枝杆菌胆固醇代谢

Kavanagh Madeline E, McLean Kirsty J, Gilbert Sophie H, Amadi Cecilia N, Snee Matthew, Tunnicliffe Richard B, Arora Kriti, Boshoff Helena I M, Fanourakis Alexander, Rebollo-Lopez Maria Jose, Ortega Fatima, Levy Colin W, Munro Andrew W, Leys David, Abell Chris, Coyne Anthony G

Fragment-based development of small molecule inhibitors targeting Mycobacterium tuberculosis cholesterol metabolism

基于片段的小分子抑制剂开发靶向结核分枝杆菌胆固醇代谢

Kavanagh, Madeline E; McLean, Kirsty J; Gilbert, Sophie H; Amadi, Cecilia; Snee, Matthew; Tunnicliffe, Richard B; Arora, Kriti; Boshoff, Helena I; Fanourakis, Alexander; Rebello-Lopez, Maria Jose; Ortega-Muro, Fatima; Levy, Colin W; Munro, Andrew W; Leys, David; Abell, Chris; Coyne, Anthony G

Corrigendum: Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors

更正:结核分枝杆菌CYP121抑制剂设计中的底物片段化

Kavanagh, Madeline E; Gray, Janine L; Gilbert, Sophie H; Coyne, Anthony G; McLean, Kirsty J; Davis, Holly J; Munro, Andrew W; Abell, Chris

Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors

结核分枝杆菌CYP121抑制剂设计的底物片段化

Kavanagh, Madeline E; Gray, Janine L; Gilbert, Sophie H; Coyne, Anthony G; McLean, Kirsty J; Davis, Holly J; Munro, Andrew W; Abell, Chris